Zymeworks据报接近以9.29亿美元收购Theravance

投资观察
Jul 03

据彭博新闻社报道,Zymeworks Inc (US) 正接近达成一项价值约9.29亿美元的收购协议,目标为Theravance Biopharma Inc.。

消息指出,Zymeworks Inc (US) 正在讨论以每股17美元的价格收购Theravance Biopharma。此项交易若最终敲定,将显著扩大Zymeworks在生物制药领域的版图。

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10